Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain. TMS is used to treat depression, tinnitus, Alzheimer's disease, Parkinson's disease, psychiatric disorders and headache. The global TMS market was valued at USD 1.2 billion in 2018 and is expected to reach USD 2.5 billion by 2030, growing at a CAGR of 8% from 2019 to 2030.
The global TMS market has been segmented on the basis of type into TMS, pTMS, rTMS and nTMS; on the basis of application into expression therapy for depression and other psychiatric disorders such as anxiety disorder or schizophrenia; tinnitus treatment; Alzheimer's disease treatment; Parkinson's disease treatment; headache treatment for chronic migraine or cluster headaches; stroke rehabilitation therapy for post-stroke motor deficits such as hemiparesis or hemiplegia etc; on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA); and forecast from 2021 to 2030.
North America accounted for the largest share in terms of revenue in 2018 owing to high adoption rates among patients with neurological disorders such as depression or Parkinson’s Disease etc, which are prevalent across this region. The US, Canada and Mexico are some major countries contributing towards this growth trend due to their large population base with high prevalence rates of neurological disorders like depression or Parkinson’s Disease etc, which can be treated using transcranial magnetic stimulation devices.
Some Of The Growth Factors Of This Market:
- TMS is a non-invasive, drug-free treatment for depression and other mental health disorders.
- TMS is a safe and effective treatment for depression that does not have the side effects of antidepressants or electroconvulsive therapy (ECT).
- The FDA has approved TMS as an adjunctive therapy to antidepressant medication in adults with major depressive disorder who have failed to achieve satisfactory improvement from prior antidepressant medication at an adequate dose and duration in the current episode of depression.
- The FDA has also approved TMS as a monotherapy for adult patients with major depressive disorder who are not adequately responding to standard antidepressant therapies, including ECT, or who cannot tolerate or refuse those treatments because of their medical condition or other reasons.
- In addition, the FDA has approved TMS as an adjunctive therapy to antipsychotic medications in adults with schizophrenia who have had an inadequate response to antipsychotic medications alone.
Industry Growth Insights published a new data on “Transcranial Magnetic Stimulators (TMS) Market”. The research report is titled “Transcranial Magnetic Stimulators (TMS) Market research by Types (TMS, pTMS, rTMS, nTMS), By Applications (epression, Tinnitus, Alzheimer, Parkinson's Disease, Psychiatric Disorders, Headache, Stroke, Other), By Players/Companies iruide, Neuronetics, Magstim, Brainsway, MagVenture, eNeura, Remed, Neurosoft, Dr. Langer Medical, Nexstim, MAG & More”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transcranial Magnetic Stimulators (TMS) Market Research Report
By Type
TMS, pTMS, rTMS, nTMS
By Application
epression, Tinnitus, Alzheimer, Parkinson's Disease, Psychiatric Disorders, Headache, Stroke, Other
By Companies
iruide, Neuronetics, Magstim, Brainsway, MagVenture, eNeura, Remed, Neurosoft, Dr. Langer Medical, Nexstim, MAG & More
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Transcranial Magnetic Stimulators (TMS) Market Report Segments:
The global Transcranial Magnetic Stimulators (TMS) market is segmented on the basis of:
Types
TMS, pTMS, rTMS, nTMS
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
epression, Tinnitus, Alzheimer, Parkinson's Disease, Psychiatric Disorders, Headache, Stroke, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- iruide
- Neuronetics
- Magstim
- Brainsway
- MagVenture
- eNeura
- Remed
- Neurosoft
- Dr. Langer Medical
- Nexstim
- MAG & More
 Market Overview.svg)
Highlights of The Transcranial Magnetic Stimulators (TMS) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- TMS
- pTMS
- rTMS
- nTMS
- By Application:
- epression
- Tinnitus
- Alzheimer
- Parkinson's Disease
- Psychiatric Disorders
- Headache
- Stroke
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transcranial Magnetic Stimulators (TMS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transcranial magnetic stimulation (TMS) is a noninvasive brain stimulation technique that uses a strong magnetic field to stimulate specific areas of the brain. TMS has been used in clinical trials to treat depression, chronic pain, and other conditions.
Some of the major companies in the transcranial magnetic stimulators (tms) market are iruide, Neuronetics, Magstim, Brainsway, MagVenture, eNeura, Remed, Neurosoft, Dr. Langer Medical, Nexstim, MAG & More.
The transcranial magnetic stimulators (tms) market is expected to register a CAGR of 8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transcranial Magnetic Stimulators (TMS) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transcranial Magnetic Stimulators (TMS) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transcranial Magnetic Stimulators (TMS) Market - Supply Chain
4.5. Global Transcranial Magnetic Stimulators (TMS) Market Forecast
4.5.1. Transcranial Magnetic Stimulators (TMS) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transcranial Magnetic Stimulators (TMS) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transcranial Magnetic Stimulators (TMS) Market Absolute $ Opportunity
5. Global Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Type
5.3.1. TMS
5.3.2. pTMS
5.3.3. rTMS
5.3.4. nTMS
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Application
6.3.1. epression
6.3.2. Tinnitus
6.3.3. Alzheimer
6.3.4. Parkinson's Disease
6.3.5. Psychiatric Disorders
6.3.6. Headache
6.3.7. Stroke
6.3.8. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transcranial Magnetic Stimulators (TMS) Demand Share Forecast, 2019-2026
9. North America Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Application
9.4.1. epression
9.4.2. Tinnitus
9.4.3. Alzheimer
9.4.4. Parkinson's Disease
9.4.5. Psychiatric Disorders
9.4.6. Headache
9.4.7. Stroke
9.4.8. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Type
9.7.1. TMS
9.7.2. pTMS
9.7.3. rTMS
9.7.4. nTMS
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transcranial Magnetic Stimulators (TMS) Demand Share Forecast, 2019-2026
10. Latin America Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Application
10.4.1. epression
10.4.2. Tinnitus
10.4.3. Alzheimer
10.4.4. Parkinson's Disease
10.4.5. Psychiatric Disorders
10.4.6. Headache
10.4.7. Stroke
10.4.8. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Type
10.7.1. TMS
10.7.2. pTMS
10.7.3. rTMS
10.7.4. nTMS
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transcranial Magnetic Stimulators (TMS) Demand Share Forecast, 2019-2026
11. Europe Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Application
11.4.1. epression
11.4.2. Tinnitus
11.4.3. Alzheimer
11.4.4. Parkinson's Disease
11.4.5. Psychiatric Disorders
11.4.6. Headache
11.4.7. Stroke
11.4.8. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Type
11.7.1. TMS
11.7.2. pTMS
11.7.3. rTMS
11.7.4. nTMS
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transcranial Magnetic Stimulators (TMS) Demand Share, 2019-2026
12. Asia Pacific Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Application
12.4.1. epression
12.4.2. Tinnitus
12.4.3. Alzheimer
12.4.4. Parkinson's Disease
12.4.5. Psychiatric Disorders
12.4.6. Headache
12.4.7. Stroke
12.4.8. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Type
12.7.1. TMS
12.7.2. pTMS
12.7.3. rTMS
12.7.4. nTMS
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transcranial Magnetic Stimulators (TMS) Demand Share, 2019-2026
13. Middle East & Africa Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Application
13.4.1. epression
13.4.2. Tinnitus
13.4.3. Alzheimer
13.4.4. Parkinson's Disease
13.4.5. Psychiatric Disorders
13.4.6. Headache
13.4.7. Stroke
13.4.8. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Type
13.7.1. TMS
13.7.2. pTMS
13.7.3. rTMS
13.7.4. nTMS
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transcranial Magnetic Stimulators (TMS) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transcranial Magnetic Stimulators (TMS) Market: Market Share Analysis
14.2. Transcranial Magnetic Stimulators (TMS) Distributors and Customers
14.3. Transcranial Magnetic Stimulators (TMS) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. iruide
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Neuronetics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Magstim
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Brainsway
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. MagVenture
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. eNeura
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Remed
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Neurosoft
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Dr. Langer Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Nexstim
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. MAG & More
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
